Pharmaceutical company Sobi says in a press release that revenue and adjusted EBITA margin for the full year 2025 exceed previous forecasts.
Despite the announcement, the stock market reacted negatively and the share price fell almost 2 percent, while the Stockholm Stock Exchange's OMXS index was up almost 1 percent at lunchtime.
Sobi's largest owner is the Wallenberg family's investment company Investor, followed by pharmaceutical giant AstraZeneca.
